Leo is not messing around. Nothing but confidence that Brilacidin will perform! We are going for the moderate to severe patients and we will make Remdesivir look like a saline solution in comparison.
2021 will be a monster year for IPIX and the world will get it’s much needed cure.
“The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled, multi-national, multi-center study expected to enroll approximately 120 patients with moderate-to-severe COVID-19”
(10)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.